genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
AI Gets Gene Therapy Over the Immunity Hump
Coronavirus
Immunai Expands from Observational to Functional Genomics
Antibody Drug Conjugates
RNA in Its DNA: Avidity Biosciences Combines mAb Selectivity, Oligonucleotide Precision
Bioprocessing
OliX Advancing in Nucleic Acid Therapeutics
CAR T-Cells
‘Manufacturing-First Approach’ Pays Off for Cell Therapy Developer Artiva
News
Genome Editing
Now on Base, Rutgers Team Reveals New Genome Editing Approach
News
Phage Therapy Successful in Mice, but Resistance Looms
OMICs
Cellular Health Maintenance System Degradation May Lead to Advanced Huntington’s
News
Atopic Dermatitis Potentially Treated by Strain of Bacteria
Diabetes
Glucagon Receptor Blockade Promotes Recovery of Functional β-Cell Mass in Diabetic…
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
COVID-19 Increasing Risk of Cyberattacks for Digital Biopharma
Bioprocessing
Case Study: How to Accelerate COVID-19 Vaccine Development
Bioprocessing
Flexibility is Key to Advances in Biomanufacturing
Bioprocessing
People Are Key to the Digital Evolution of Biopharma
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Upcoming Webinars
Solving Metadata Management from Sample Provenance through Omics
Bioprocessing
COVID-19 Increasing Risk of Cyberattacks for Digital Biopharma
Bioprocessing
Case Study: How to Accelerate COVID-19 Vaccine Development
Bioprocessing
Flexibility is Key to Advances in Biomanufacturing
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Regulatory
Regulatory
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Regulatory
Industry Groups Fire Back as Trump Proposes Cutting Part B Medicare Drug Costs
Regulatory
Protalix’ Phase III Candidate for Gaucher’s May Fill the Treatment Gap due to Genzyme’s Plant Closure
Regulatory
Shire’s Gaucher Disease Drug Candidate Being Considered by FDA
Regulatory
DNA Probe–Based Patch Offers Novel Approach to Detecting Food Contamination
Regulatory
Autism Risk Increased through Structural Variants Inherited from Dad
Regulatory
Cell Therapeutics to Appeal FDA Decision on Pixantrone NDA
Regulatory
GSK’s BPH Therapy Receives European Clearance
Regulatory
FDA Clears Hologic’s HPV 16, 18/45 Genotype Assay
Regulatory
Orexo Receives FDA Green Light for Insomnia Drug
Regulatory
EU Clears Avastin as Combo Therapy for Recurrent Ovarian Cancer
Regulatory
EU Sanctions Novartis Drug for Steroid-Induced Osteoporosis
Regulatory
FDA Gives Abbott a Thumbs-Up for Automated HBV Monitoring Test
Regulatory
Novartis’ Lucentis Approved in Europe for Treating Macular Edema Secondary to...
Regulatory
Merck Serono Gives Up on Getting Drug Candidate for Multiple Sclerosis...
Regulatory
Amgen, Novartis Set to Launch Migraine Drug Aimovig Next Week after...
1
2
3
...
16
Page 1 of 16
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Agency had asked that an additional clinical study be conducted in relapsed/refractory aggressive NHL. [Andrew S. - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/Sept14_2010_10577615_SpilledRxBottle_CTIappealsFDAdecision8322613310-324x160.jpg "Cell Therapeutics to Appeal FDA Decision on Pixantrone NDA")
